Is stem cell therapy for Liver Cirrhosis FDA-approved?
No generic stem-cell or exosome product is FDA-approved to treat cirrhosis. A trial listing, autologous source or hospital setting does not constitute product approval for the indication.
How stem cells are studied for Liver Cirrhosis
Cirrhosis is advanced liver scarring caused by different diseases and can lead to portal hypertension, infection, encephalopathy, cancer and liver failure. Cell proposals aim to influence inflammation or regeneration, but a laboratory mechanism does not show reversal of established fibrosis or restored liver function. Product source, processing, route and disease cause matter.
Am I a candidate? → · Liver Cirrhosis: full overview → · Liver Cirrhosis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Liver Cirrhosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Liver Cirrhosis cost? (2026)
- Liver Cirrhosis stem cell therapy — your questions answered (2026)
- Liver Cirrhosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Liver Cirrhosis: what the registries show